Sara Kenkare-Mitra, PhD, is a HealthTech leader as President & Head of R&D at Alector, pioneering immuno-neurology for neurodegenerative diseases. A seasoned biotech executive, she’s driven 11 novel drug approvals and 100+ IND/CTA submissions. Also a UCSF professor & Unicycive board member, her work advances novel therapies for critical unmet needs.
666 3rd Ave, 6th Floor, New York, NY 10017